stanozolol has been researched along with Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brasil, GA; da Silva, CL; de Andrade, TU; de Lima, EM; de Souza Andrade Moraes, F; do Nascimento, AM; Dubois Filho, DG; Falsoni, RMP; Haguihara, SCGC | 1 |
| Cunliffe, WJ; Menon, IS | 1 |
2 other study(ies) available for stanozolol and Inflammation
| Article | Year |
|---|---|
Stanozolol promotes lipid deposition in the aorta through an imbalance in inflammatory cytokines and oxidative status in LDLr knockout mice fed a normal diet.
Topics: Anabolic Agents; Animals; Aorta; Atherosclerosis; Cytokines; Disease Models, Animal; Disease Progression; Inflammation; Inflammation Mediators; Lipid Metabolism; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Oxidation-Reduction; Oxidative Stress; Receptors, LDL; Stanozolol | 2019 |
The association between cutaneous vasculitis and decreased blood fibrinolytic activity.
Topics: Adolescent; Adult; Aged; Arteritis; Arthritis, Rheumatoid; Erythema Multiforme; Erythema Nodosum; Ethylestrenol; Female; Fibrinolysis; Fibromyalgia; Humans; Inflammation; Male; Middle Aged; Phenformin; Pigmentation Disorders; Polyarteritis Nodosa; Purpura; Serum Globulins; Skin; Skin Diseases; Stanozolol; Vascular Diseases | 1971 |